News
GLP-1 agonist shortage will last until end of 2024, government warns
BMJ 2024; 384 doi: https://doi.org/10.1136/bmj.q28 (Published 05 January 2024) Cite this as: BMJ 2024;384:q28
- Elisabeth Mahase
- The BMJ
The supply of glucagon-like peptide-1 (GLP-1) receptor agonists is not expected to return to normal until at least the end of 2024, the Department of Health and Social Care for England has warned,1 given the shortages caused by increased demand and off-label use.
Clinicians have been told not to prescribe GLP-1 agonists …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.